Zydus Lifesciences Limited (BOM:532321)
India · Delayed Price · Currency is INR 896.60
-7.00 (-0.77%)
At close: Mar 27, 2026
Zydus Lifesciences Revenue
Zydus Lifesciences had revenue of 68.65B INR in the quarter ending December 31, 2025, with 30.28% growth. This brings the company's revenue in the last twelve months to 260.89B, up 17.27% year-over-year. In the fiscal year ending March 31, 2025, Zydus Lifesciences had annual revenue of 232.42B with 18.90% growth.
Revenue (ttm)
260.89B
Revenue Growth
+17.27%
P/S Ratio
3.46
Revenue / Employee
9.35M
Employees
27,917
Market Cap
902.29B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 232.42B | 36.94B | 18.90% |
| Mar 31, 2024 | 195.47B | 23.10B | 13.40% |
| Mar 31, 2023 | 172.37B | 21.28B | 14.08% |
| Mar 31, 2022 | 151.10B | 7.06B | 4.90% |
| Mar 31, 2021 | 144.04B | 1.50B | 1.06% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Dr. Reddy's Laboratories | 345.83B |
| Lupin | 261.51B |
| Torrent Pharmaceuticals | 127.42B |
| Jubilant Pharmova | 79.18B |
| Abbott India | 68.24B |
| Granules India | 50.92B |
| J. B. Chemicals & Pharmaceuticals | 41.93B |
| GlaxoSmithKline Pharmaceuticals | 38.01B |
Zydus Lifesciences News
- 2 days ago - Zydus Lifesciences reports insider trading violation involving Rs 9,027 transaction - Business Upturn
- 4 days ago - Zydus Lifesciences faces Rs 3.28 crore demand order over input tax credit issue - Business Upturn
- 8 days ago - Zydus launches Semaglutide Injection in reusable pen device in India - Business Upturn
- 10 days ago - Zydus launches Aerolife Mini to enhance inhaler use for asthma and COPD - Business Upturn
- 11 days ago - Zydus and Torrent Pharma partner to co-market Semaglutide Injection in India - Business Upturn
- 12 days ago - Zydus and Lupin sign agreement to co-market Semaglutide injection in India - Business Upturn
- 16 days ago - Zydus Lifesciences shares in focus today after receiving USFDA approval for Cevimeline Hydrochloride Capsules - Business Upturn
- 27 days ago - Top stocks for trade today, March 2: Tata Motors, Hero MotoCorp, Zydus Lifesciences, Aurobindo Pharma, Vedanta and more - Business Upturn